95 related articles for article (PubMed ID: 23100616)
1. Question 3: Inhaled mannitol improves lung function in patients with cystic fibrosis.
Winckworth LC; Holme H
Arch Dis Child; 2012 Nov; 97(11):1003-6. PubMed ID: 23100616
[No Abstract] [Full Text] [Related]
2. Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K; Bilton D
Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
[TBL] [Abstract][Full Text] [Related]
3. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
Teper A; Jaques A; Charlton B
J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
[TBL] [Abstract][Full Text] [Related]
4. Inhaled mannitol improves lung function in cystic fibrosis.
Jaques A; Daviskas E; Turton JA; McKay K; Cooper P; Stirling RG; Robertson CF; Bye PTP; LeSouëf PN; Shadbolt B; Anderson SD; Charlton B
Chest; 2008 Jun; 133(6):1388-1396. PubMed ID: 18339790
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation.
Middleton A; Robinson PD; McKay K; Jaffe A; Selvadurai H
Eur Respir J; 2015 Feb; 45(2):541-4. PubMed ID: 25359334
[No Abstract] [Full Text] [Related]
6. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
[TBL] [Abstract][Full Text] [Related]
7. NICE guidance on inhaled mannitol for treatment of cystic fibrosis.
Jennings G; Jonsson PF; George E; Adler AI
Lancet Respir Med; 2013 Mar; 1(1):e19-20. PubMed ID: 24321814
[No Abstract] [Full Text] [Related]
8. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
Prescrire Int; 2014 Apr; 23(148):89-91. PubMed ID: 24860889
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Mannitol (Bronchitol) for Cystic Fibrosis.
Nolan SJ; Thornton J; Murray CS; Dwyer T
Paediatr Respir Rev; 2016 Mar; 18():52-4. PubMed ID: 26867712
[No Abstract] [Full Text] [Related]
10. Cystic fibrosis papers of the year 2012.
Doull I
Paediatr Respir Rev; 2013 May; 14 Suppl 1():28-30. PubMed ID: 23452761
[TBL] [Abstract][Full Text] [Related]
11. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis.
Bilton D; Bellon G; Charlton B; Cooper P; De Boeck K; Flume PA; Fox HG; Gallagher CG; Geller DE; Haarman EG; Hebestreit HU; Kolbe J; Lapey A; Robinson P; Wu J; Zuckerman JB; Aitken ML;
J Cyst Fibros; 2013 Jul; 12(4):367-76. PubMed ID: 23234802
[TBL] [Abstract][Full Text] [Related]
12. Inhaled mannitol (Bronchitol) for cystic fibrosis.
Med Lett Drugs Ther; 2021 May; 63(1625):85-86. PubMed ID: 34101719
[No Abstract] [Full Text] [Related]
13. Hitting the target: new treatments for cystic fibrosis.
Davis SD; Ferkol TW
Am J Respir Crit Care Med; 2010 Dec; 182(12):1460-1. PubMed ID: 21159902
[No Abstract] [Full Text] [Related]
14. Inhaled hypertonic saline as a therapy for cystic fibrosis.
Elkins MR; Bye PT
Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
[TBL] [Abstract][Full Text] [Related]
15. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
Minasian C; Wallis C; Metcalfe C; Bush A
Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410
[TBL] [Abstract][Full Text] [Related]
16. Repurposing excipients as active inhalation agents: The mannitol story.
Anderson SD; Daviskas E; Brannan JD; Chan HK
Adv Drug Deliv Rev; 2018 Aug; 133():45-56. PubMed ID: 29626547
[TBL] [Abstract][Full Text] [Related]
17. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
[TBL] [Abstract][Full Text] [Related]
18. [Role of inhaled corticoids].
Le Bourgeois M
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S157-60. PubMed ID: 12910149
[No Abstract] [Full Text] [Related]
19. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.
Grasemann H; Kurtz F; Ratjen F
Am J Respir Crit Care Med; 2006 Jul; 174(2):208-12. PubMed ID: 16627863
[TBL] [Abstract][Full Text] [Related]
20. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
Adi H; Young PM; Chan HK; Agus H; Traini D
Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
